The effect of food on plasma and tissue concentrations of linezolid after multiple doses

被引:20
作者
Islinger, F
Dehghanyar, P
Sauermann, R
Bürger, C
Kloft, C
Müller, M
Joukhadar, C
机构
[1] Med Univ Vienna, Div Clin Pharmacokinet, Dept Clin Pharmacol, A-1090 Vienna, Austria
[2] Free Univ Berlin, Dept Clin Pharm, Berlin, Germany
[3] Med Univ Vienna, Div Infect Dis & Chemotherapy, Dept Internal Med 1, Vienna, Austria
关键词
linezolid; absorption; food; tissue pharmacokinetics;
D O I
10.1016/j.ijantimicag.2005.09.017
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In the present pilot study we investigated the effect of food ingestion on target site pharmacokinetics of linezolid, the first clinically approved oxazolidinone. For this purpose we determined free concentrations of linezolid at steady state in the interstitial space fluid of skeletal muscle and subcutaneous adipose tissue under fasting and non-fasting conditions in healthy Volunteers (n = 9) by means of in vivo microdialysis. Ingestion of food led to a marked delay in the time to reach the peak concentration (T-max), whereas the area under the concentration-time curve from 0 to 24h (AUC(0-24)h,) remained unchanged. These data suggest that the rate of linezolid absorption is decreased by food intake. However, the overall extent of linezolid absorption and the distribution of linezolid were not affected. Tissue levels of linezolid appeared sufficiently high to eradicate pathogens with a minimum inhibitory concentration of <= 4 mg/L. (c) 2005 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:108 / 112
页数:5
相关论文
共 17 条
[1]   Development of a liquid chromatography method for the determination of linezolid and its application to in vitro and human microdialysis samples [J].
Buerger, C ;
Joukhadar, C ;
Muller, M ;
Kloft, C .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 796 (01) :155-164
[2]   Basic pharmacodynamics of antibacterials with clinical applications to the use of β-lactams, glycopeptides, and linezolid [J].
Craig, WA .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2003, 17 (03) :479-+
[3]   Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses [J].
Dehghanyar, P ;
Bürger, C ;
Zeitlinger, M ;
Islinger, F ;
Kovar, F ;
Müller, M ;
Kloft, C ;
Joukhadar, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (06) :2367-2371
[4]   Oxazolidinone antibiotics [J].
Diekema, DJ ;
Jones, RN .
LANCET, 2001, 358 (9297) :1975-1982
[5]   Pharmacokinetics and tissue penetration of linezolid following multiple oral doses [J].
Gee, T ;
Ellis, R ;
Marshall, G ;
Andrews, J ;
Ashby, J ;
Wise, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1843-1846
[6]   Susceptibility of a variety of clinical isolates to linezolid: a European inter-country comparison [J].
Gemmell, CG .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (01) :47-52
[7]   Macrolide-resistant group a streptococcus - Now in the United States [J].
Huovinen, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (16) :1243-1245
[8]   Microdialysis -: Current applications in clinical pharmacokinetic studies and its potential role in the future [J].
Joukhadar, C ;
Müller, M .
CLINICAL PHARMACOKINETICS, 2005, 44 (09) :895-913
[9]   Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans [J].
Joukhadar, C ;
Stass, H ;
Müller-Zellenberg, U ;
Lackner, E ;
Kovar, F ;
Minar, E ;
Müller, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (10) :3099-3103
[10]   Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections [J].
MacGowan, AP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 :17-25